ECSP12011577A - Produccion recombinante de péptidos - Google Patents

Produccion recombinante de péptidos

Info

Publication number
ECSP12011577A
ECSP12011577A EC2012011577A ECSP12011577A ECSP12011577A EC SP12011577 A ECSP12011577 A EC SP12011577A EC 2012011577 A EC2012011577 A EC 2012011577A EC SP12011577 A ECSP12011577 A EC SP12011577A EC SP12011577 A ECSP12011577 A EC SP12011577A
Authority
EC
Ecuador
Prior art keywords
peptides
recombinant production
precursor proteins
assembled
self
Prior art date
Application number
EC2012011577A
Other languages
English (en)
Inventor
Theodor Fehr
Daniel Hümmerich
Burghard Liebmann
Carsten Schwalb
Heike Brüser
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of ECSP12011577A publication Critical patent/ECSP12011577A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a proteínas precursoras repetitivas autoensambladas, secuencias de ácidos nucleicos y constructos de expresión que los codifican, y a métodos para la producción recombinante de péptidos mediante el uso de dichas proteínas precursoras.
EC2012011577A 2009-06-03 2012-01-06 Produccion recombinante de péptidos ECSP12011577A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09161837 2009-06-03

Publications (1)

Publication Number Publication Date
ECSP12011577A true ECSP12011577A (es) 2012-02-29

Family

ID=43298234

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2012011577A ECSP12011577A (es) 2009-06-03 2012-01-06 Produccion recombinante de péptidos

Country Status (20)

Country Link
US (1) US9481719B2 (es)
EP (1) EP2437769B1 (es)
JP (1) JP5730293B2 (es)
KR (2) KR101834018B1 (es)
CN (1) CN102724992B (es)
AR (1) AR076977A1 (es)
AU (1) AU2010255732B8 (es)
BR (1) BRPI1011144B8 (es)
CA (1) CA2763626A1 (es)
CL (1) CL2011003075A1 (es)
CR (1) CR20110619A (es)
EC (1) ECSP12011577A (es)
ES (1) ES2763168T3 (es)
IL (1) IL216619A0 (es)
MX (1) MX2011012906A (es)
NZ (2) NZ615847A (es)
PE (1) PE20121033A1 (es)
RU (1) RU2548815C2 (es)
TW (1) TWI429750B (es)
WO (1) WO2010139736A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2597743A1 (en) * 2005-02-24 2006-08-31 The University Of Queensland Peptide networks
WO2012079125A1 (en) * 2010-12-14 2012-06-21 The University Of Queensland Designed biosurfactants, their manufacture, purification and use
CN103740661B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
CN103756979B (zh) * 2012-05-10 2015-07-08 江南大学 一种提高酶热稳定性的方法
CN103740659B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
CA2877301A1 (en) * 2012-06-20 2013-12-27 Michael J. Heller Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems
CN104755502B (zh) * 2012-10-12 2018-05-18 清华大学 多肽的产生和纯化方法
WO2017055587A1 (de) * 2015-10-01 2017-04-06 Basf Se Rekombinante herstellung von peptiden
KR101976923B1 (ko) * 2017-05-10 2019-05-10 건국대학교 산학협력단 D-루이신 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
KR101970876B1 (ko) * 2017-05-10 2019-04-19 건국대학교 산학협력단 D-라이신 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
KR101970875B1 (ko) * 2017-05-10 2019-04-19 건국대학교 산학협력단 글루탐산 치환을 통해 항균 효과를 증진시킨 항생 펩타이드 및 이의 용도
CN106496307B (zh) * 2016-11-09 2019-11-01 湖南科技学院 一种新的抗菌肽及其用途
CN108503690B (zh) * 2017-02-28 2020-07-03 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
WO2018157773A1 (zh) 2017-02-28 2018-09-07 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
WO2020048996A1 (en) 2018-09-06 2020-03-12 ETH Zürich Self-assembling globular proteins and uses thereof
CN111388374B (zh) * 2020-04-11 2022-09-06 百草堂(湖北)制药有限公司 一种洗发露
EP4277917A4 (en) 2021-01-14 2024-06-19 Biocatalyst LLC Compositions and methods for peptide production
CN116874613B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种广谱高效的抗菌多肽aph143及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504761D0 (en) 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
KR100263583B1 (ko) * 1997-05-28 2000-08-01 박종헌 항균 펩타이드의 대량 제조방법 및 그에 유용한 플라즈미드 벡타
WO2000031279A2 (en) * 1998-11-20 2000-06-02 Micrologix Biotech Inc. Producing antimicrobial cationic peptides as fusion proteins
US7288391B2 (en) * 2001-06-06 2007-10-30 University Of Wyoming Expression of spider silk proteins in higher plants
KR100438416B1 (ko) 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
DE60215534T2 (de) 2001-11-20 2007-09-20 Novozymes A/S Antimikrobielle polypeptide aus pseudoplectania nigrella
US20030219854A1 (en) 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
JP4472998B2 (ja) 2002-04-22 2010-06-02 ダウ グローバル テクノロジーズ インコーポレイティド 低コストのペプチド製造
CA2519023C (en) 2003-03-17 2014-05-20 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
ES2525095T3 (es) * 2004-07-22 2014-12-17 Amsilk Gmbh Proteínas recombinantes de la seda de araña
RU2421463C2 (ru) * 2005-08-29 2011-06-20 АЭмЗильк ГмбХ Способ модификации белка шелка пауков, модифицированный белок шелка пауков, кодирующая его последовательность нуклеиновой кислоты, вектор и клетка-хозяин для его экспрессии
US7709227B2 (en) 2006-01-04 2010-05-04 Phasebio Pharmaceuticals, Inc. Multimeric ELP fusion constructs
CN101370556A (zh) 2006-01-20 2009-02-18 巴斯夫欧洲公司 蛋白质微粒在化妆品中的用途
CA2685308A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
WO2008155304A1 (de) * 2007-06-20 2008-12-24 Basf Se Synthetische repetitive proteine, deren herstellung und verwendung
CA2708554C (en) * 2007-12-21 2014-04-22 Basf Se Anti-dandruff compositions containing peptides

Also Published As

Publication number Publication date
NZ596735A (en) 2013-10-25
RU2548815C2 (ru) 2015-04-20
JP5730293B2 (ja) 2015-06-10
EP2437769B1 (de) 2019-09-25
BRPI1011144A2 (pt) 2016-10-25
WO2010139736A2 (de) 2010-12-09
EP2437769A2 (de) 2012-04-11
KR101812842B1 (ko) 2017-12-27
AU2010255732B8 (en) 2014-03-13
TWI429750B (zh) 2014-03-11
CN102724992A (zh) 2012-10-10
ES2763168T3 (es) 2020-05-27
WO2010139736A3 (de) 2011-03-10
KR20120014940A (ko) 2012-02-20
TW201103981A (en) 2011-02-01
CN102724992B (zh) 2016-05-18
AU2010255732A8 (en) 2014-03-13
KR20140127344A (ko) 2014-11-03
AU2010255732B2 (en) 2013-09-12
AR076977A1 (es) 2011-07-20
KR101834018B1 (ko) 2018-03-05
CA2763626A1 (en) 2010-12-09
BRPI1011144B8 (pt) 2021-05-25
PE20121033A1 (es) 2012-08-02
CR20110619A (es) 2012-02-09
US20120088268A1 (en) 2012-04-12
BRPI1011144B1 (pt) 2021-02-02
US9481719B2 (en) 2016-11-01
MX2011012906A (es) 2012-02-01
AU2010255732A1 (en) 2011-12-22
JP2012528579A (ja) 2012-11-15
CL2011003075A1 (es) 2012-06-29
IL216619A0 (en) 2012-02-29
NZ615847A (en) 2014-11-28
RU2011153757A (ru) 2013-07-20

Similar Documents

Publication Publication Date Title
CR20110619A (es) Produccion recombinante de peptidos
AR113177A2 (es) Polipéptidos que tienen actividad de lisozima y polinucleótidos que los codifican
MX2014005728A (es) Anticuerpos especificos para antigeno de la superficie celular de trofoblasto-2 y sus usos.
AR122864A2 (es) Variantes de lipasa y polinucleótidos que las codifican
ES2597877T3 (es) Promotor mejorado y método para la producción de L-lisina mediante el uso del mismo
BR112012008173A2 (pt) molécula de ligação específica de rsv
CR20110544A (es) Anticuerpo antagonista específico para el heterodímero de alfa-4-beta-7
EA201171325A1 (ru) Нуклеиновые кислоты, связывающиеся с гепсидином
UY35456A (es) Moléculas de unión para bcma y cd3
CL2013001124A1 (es) Anticuerpo aislado o una proteína que comprende una porción de enlace de antígeno de un anticuerpo dirigido contra un polipéptido de cd40; composicion farmacéutica que comprende dicho anticuerpo; ácido nucleico que codifica el anticuerpo; vector de clonación; proceso de producción del anticuerpo.
MX2013015393A (es) Inmunocitosinas basadas en un dominio sushi de il-15 y de il-15ra.
MX2014005108A (es) Constructos de polipeptidos y sus usos.
BR112012015740A2 (pt) anticorpos de anti-flt3 e metodos de uso dos mesmos
EA201590994A1 (ru) Способ увеличения гидродинамического объема полипептида путем присоединения карбоксиконцевого пептида гонадотропина
CL2012000886A1 (es) Polipeptido que comprende dos secuencias aminoacidas que permiten la union especifica al receptor para productos finales de glicosilacion avanzada (rpfga); uno o mas acidos nucleicos que codifican el polipeptido; celula; composicion; metodo para diagnosticar enfermedad o trastorno con rpfga.
MX342171B (es) Peptido o complejo peptidico que se une a integrina ?2 y metodos y usos que implican a los mismos.
MX389370B (es) Microorganismo recombinante para la produccion mejorada de quimicos finos.
GB201214580D0 (en) Benzocyanine compounds
BR112015000982B8 (pt) Método para a obtenção de uma molécula de ácido nucleico sintético
MX2011012623A (es) Construcciones de casb7439.
UY39980A (es) Manipulación de la Auto-incompatibilidad en Plantas
CO6450617A2 (es) Produccion de hidrocarburos de isopreno mejorada que usa cianobacterias diseñadas geneticamente
BR112017021401A2 (pt) produção de compostos fragrantes
CU20120045A7 (es) Molécula de ácido nucleico que codifica una sintasa de triterpenoide
BR112014007174A2 (pt) método para produzir fragmento de polipeptídeo com alta eficiência, que é adequado para o método ncl